An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma

Adarsh Gopinathana Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

Runali Sankhea Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

Ekta Rathib Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

Triveni Kodia Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

Raghavendra Upadhyac Manipal Center for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

K. Sreedhara Ranganath Paia Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaView further author information

Anoop Kishorea Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IndiaCorrespondence[email protected]
View further author information

show all

An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date